Gene · 4481
Papers3,855
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 3,855
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Asprosin inhibits macrophage lipid accumulation and reduces atherosclerotic burden by up-regulating ABCA1 and ABCG1 expression via the p38/Elk-1 pathway. | J Transl Med | 2022 | 35902881 | PubTator, text mining | PubMed |
| Inhalable Formulation Based on Lipid-Polymer Hybrid Nanoparticles for the Macrophage Targeted Delivery of Roflumilast. | Biomacromolecules | 2022 | 35899612 | PubTator, text mining | PubMed |
| Signal Peptide Features Determining the Substrate Specificities of Targeting and Translocation Components in Human ER Protein Import. | Front Physiol | 2022 | 35899032 | PubTator, text mining | PubMed |
| The Emerging Role of Immune Cells and Targeted Therapeutic Strategies in Diabetic Wounds Healing. | J Inflamm Res | 2022 | 35898820 | PubTator, text mining | PubMed |
| Glial Fibrillary Acidic Protein: A Biomarker and Drug Target for Alzheimer's Disease. | Pharmaceutics | 2022 | 35890250 | PubTator, text mining | PubMed |
| Analyzing the Systems Biology Effects of COVID-19 mRNA Vaccines to Assess Their Safety and Putative Side Effects. | Pathogens | 2022 | 35889989 | PubTator, text mining | PubMed |
| The Problem of Wound Healing in Diabetes-From Molecular Pathways to the Design of an Animal Model. | Int J Mol Sci | 2022 | 35887276 | PubTator, text mining | PubMed |
| A Quantitative Digital Analysis of Tissue Immune Components Reveals an Immunosuppressive and Anergic Immune Response with Relevant Prognostic Significance in Glioblastoma. | Biomedicines | 2022 | 35885058 | PubTator, text mining | PubMed |
| Resveratrol and ω-3 PUFAs Promote Human Macrophage Differentiation and Function. | Biomedicines | 2022 | 35884829 | PubTator, text mining | PubMed |
| [Gastric cancer-derived mesenchymal stem cells regulate the M2 polarization of macrophages within gastric cancer microenvironment via JAK2/STAT3 signaling pathway]. | Zhonghua Zhong Liu Za Zhi | 2022 | 35880339 | PubTator, text mining | PubMed |
| The complex role of tumor-infiltrating macrophages. | Nat Immunol | 2022 | 35879449 | PubTator, text mining | PubMed |
| Role and Mechanisms of Tumor-Associated Macrophages in Hematological Malignancies. | Front Oncol | 2022 | 35875135 | PubTator, text mining | PubMed |
| Metabolic Reprogramming Induces Macrophage Polarization in the Tumor Microenvironment. | Front Immunol | 2022 | 35874739 | PubTator, text mining | PubMed |
| The emergence of tumor-infiltrating lymphocytes in nasopharyngeal carcinoma: Predictive value and immunotherapy implications. | Genes Dis | 2022 | 35873027 | PubTator, text mining | PubMed |
| Single-Cell Transcriptome Analysis Reveals Mesenchymal Stem Cells in Cavernous Hemangioma. | Front Cell Dev Biol | 2022 | 35865633 | PubTator, text mining | PubMed |
| Single-cell analysis of endometriosis reveals a coordinated transcriptional programme driving immunotolerance and angiogenesis across eutopic and ectopic tissues. | Nat Cell Biol | 2022 | 35864314 | PubTator, text mining | PubMed |
| Trained Immunity in Primary Sjögren's Syndrome: Linking Type I Interferons to a Pro-Atherogenic Phenotype. | Front Immunol | 2022 | 35860283 | PubTator, text mining | PubMed |
| CD40×HER2 bispecific antibody overcomes the CCL2-induced trastuzumab resistance in HER2-positive gastric cancer. | J Immunother Cancer | 2022 | 35851310 | PubTator, text mining | PubMed |
| Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy. | Front Immunol | 2022 | 35844605 | PubTator, text mining | PubMed |
| The Crosstalk Between Liver Sinusoidal Endothelial Cells and Hepatic Microenvironment in NASH Related Liver Fibrosis. | Front Immunol | 2022 | 35837401 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4481/papers?page=46